[1]
|
Ekberg, J. and Adams, D.J. (2006) Neuronal Voltage-Gated Sodium Channel Subtypes: Key Roles in Inflammatory and Neuropathic Pain. Int J Biochem Cell Biol., 38, 2005-2010. https://doi.org/10.1016/j.biocel.2006.06.008
|
[2]
|
Payandeh, J., Gamal El-Din, T.M., Scheuer, T., et al. (2012) Crystal Structure of a Voltage-Gated Sodium Channel in Two Potentially Inactivated States. Nature, 486, 135-139. https://doi.org/10.1038/nature11077
|
[3]
|
Blechschmidt, S., Haufe, V., Benndorf, K., et al. (2008) Voltage-Gated Na+ Channel Transcript Patterns in the Mammalian Heart Are Species-Dependent. Prog Biophys Mol Biol, 98, 309-318.
https://doi.org/10.1016/j.pbiomolbio.2009.01.009
|
[4]
|
Thakor, D.K., Lin, A., Matsuka, Y., et al. (2009) Increased Peripheral Nerve Excitability and Local NaV1.8 mRNA Up-Regulation in Painful Neuropathy. Mol Pain, 5, 14. https://doi.org/10.1186/1744-8069-5-14
|
[5]
|
Coward, K., Plumpton, C., Facer, P., et al. (2000) Immunolocalization of SNS/PN3 and NaN/SNS2 Sodium Channels in Human Pain States. Pain, 85, 41-50. https://doi.org/10.1016/S0304-3959(99)00251-1
|
[6]
|
Verkerk, A.O., Remme, C.A., Schumacher, C.A., et al. (2012) Functional Nav1.8 Channels in Intracardiac Neurons: The Link between SCN10A and Cardiac Electrophysiology. Circ Res., 111, 333-343.
https://doi.org/10.1161/CIRCRESAHA.112.274035
|
[7]
|
Facer, P., Punjabi, P.P., Abrari, A., et al. (2011) Localisation of SCN10A Gene Product Na(v)1.8 and Novel Pain-Related Ion Channels in Human Heart. International Heart Journal, 52, 146-152.
https://doi.org/10.1536/ihj.52.146
|
[8]
|
van den Boogaard, M., Smemo, S., Burnicka-Turek, O., et al. (2014) A Common Genetic Variant within SCN10A Modulates Cardiac SCN5A Expression. J Clin Invest, 124, 1844-1852. https://doi.org/10.1172/JCI73140
|
[9]
|
Yang, T., Atack, T.C., Stroud, D.M., et al. (2012) Blocking Scn10a Channels in Heart Reduces Late Sodium Current and Is Antiarrhythmic. Circ Res., 111, 322-332. https://doi.org/10.1161/CIRCRESAHA.112.265173
|
[10]
|
Chambers, J.C., Zhao, J., Terracciano, C.M., et al. (2010) Genetic Variation in SCN10A Influences Cardiac Conduction. Nat Genet., 42, 149-152. https://doi.org/10.1038/ng.516
|
[11]
|
Crotti, L., Celano, G., Dagradi, F., et al. (2008) Congenital Long QT Syndrome. Orphanet J Rare Dis., 3, 18.
https://doi.org/10.1186/1750-1172-3-18
|
[12]
|
Clancy, C.E., Tateyama, M., Liu, H., et al. (2003) Non-Equilibrium Gating in Cardiac Na+ Channels: An Original Mechanism of Arrhythmia. Circulation, 107, 2233-2237. https://doi.org/10.1161/01.CIR.0000069273.51375.BD
|
[13]
|
Wang, D.W., Yazawa, K., George Jr., A.L., et al. (1996) Characterization of Human Cardiac Na+ Channel Mutations in the Congenital Long QT Syndrome. Proc Natl Acad Sci USA, 93, 13200-13205.
https://doi.org/10.1073/pnas.93.23.13200
|
[14]
|
Makita, N., Behr, E., Shimizu, W., et al. (2008) The E1784K Mutation in SCN5A Is Associated with Mixed Clinical Phenotype of Type 3 Long QT Syndrome. J Clin Invest., 118, 2219-2229. https://doi.org/10.1172/JCI34057
|
[15]
|
Kanters, J.K., Yuan, L., Hedley, P.L., et al. (2014) Flecainide Provocation Reveals Concealed Brugada Syndrome in a Long QT Syndrome Family with a Novel L1786Q Mutation in SCN5A. Circ J., 78, 1136-1143.
https://doi.org/10.1253/circj.CJ-13-1167
|
[16]
|
Song, W. and Shou, W. (2012) Cardiac Sodium Channel Nav1.5 Mutations and Cardiac Arrhythmia. Pediatr Cardiol., 33, 943-949. https://doi.org/10.1007/s00246-012-0303-y
|
[17]
|
Wilde, A.A., Antzelevitch, C., Borggrefe, M., Brugada, J., Bru-gada, R., Brugada, P., et al. (2002) Proposed Diagnostic Criteria for the Brugada Syndrome: Consensus Report. Circulation, 106, 2514-2519.
https://doi.org/10.1161/01.CIR.0000034169.45752.4A
|
[18]
|
Wilde, A.A., Postema, P.G., Di Diego, J.M., et al. (2010) The Pathophysiological Mechanism Underlying Brugada Syndrome: Depolarization versus Repolarization. J Mol Cell Cardiol., 49, 543-553.
https://doi.org/10.1016/j.yjmcc.2010.07.012
|
[19]
|
Moreau, A., Keller, D.I., Huang, H., et al. (2012) Mexiletine Differentially Restores the Trafficking Defects Caused by Two Brugada Syndrome Mutations. Front Pharmacol., 3, 62. https://doi.org/10.3389/fphar.2012.00062
|
[20]
|
Ortiz-Bonnin, B., Rinné, S., Moss, R., et al. (2016) Elec-trophysiological Characterization of a Large Set of Novel Variants in the SCN5A-Gene: Identification of Novel LQTS3 and BrS Mutations. Pflugers Arch., 468, 1375-1387.
https://doi.org/10.1007/s00424-016-1844-3
|
[21]
|
Veltmann, C., Barajas-Martinez, H., Wolpert, C., et al. (2016) Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect. J Am Heart Assoc., 5, pii: e003379. https://doi.org/10.1161/JAHA.116.003379
|
[22]
|
Samani, K., Wu, G., Ai, T., et al. (2009) A Novel SCN5A Mutation V1340I in Brugada Syndrome Augmenting Arrhythmias during Febrile Illness. Heart Rhythm., 6, 1318-1326. https://doi.org/10.1016/j.hrthm.2009.05.016
|
[23]
|
Hu, D., Barajas-Martínez, H., Pfeiffer, R., et al. (2014) Mutations in SCN10A Are Responsible for a Large Fraction of Cases of Brugada Syndrome. J Am Coll Cardiol., 64, 66-79. https://doi.org/10.1016/j.jacc.2014.04.032
|
[24]
|
Benson, D.W., Wang, D.W., Dyment, M., et al. (2003) Congenital Sick Sinus Syndrome Caused by Recessive Mutations in the Cardiac Sodium Channel Gene (SCN5A). J Clin Invest., 112, 1019-1028.
https://doi.org/10.1172/JCI200318062
|
[25]
|
Adán, V. and Crown, L.A. (2003) Diagnosis and Treatment of Sick Sinus Syndrome. Am Fam Physician., 67, 1725-1732.
|
[26]
|
Veldkamp, M.W., Wilders, R., Baartscheer, A., et al. (2003) Contribution of Sodium Channel Mutations to Bradycardia and Sinus Node Dysfunction in LQT3 Families. Circ Res., 92, 976-983.
https://doi.org/10.1161/01.RES.0000069689.09869.A8
|
[27]
|
Gregoratos, G. (2003) Cardiology Patient Pages. Sick Sinus Syndrome. Circulation, 108, e143-144.
https://doi.org/10.1161/01.CIR.0000102938.55119.EC
|
[28]
|
Kawaguchi, T., Hayashi, H., Miyamoto, A., et al. (2013) Prognostic Implications of Progressive Cardiac Conduction Disease. Circ J., 77, 60-67. https://doi.org/10.1253/circj.CJ-12-0849
|
[29]
|
Probst, V., Kyndt, F., Potet, F., et al. (2003) Haploinsufficiency in Combination with Aging Causes SCN5A-Linked Hereditary Lenègre Disease. J Am Coll Cardiol., 41, 643-652. https://doi.org/10.1016/S0735-1097(02)02864-4
|
[30]
|
Meregalli, P.G., Tan, H.L., Probst, V., et al. (2009) Type of SCN5A Mutation Determines Clinical Severity and Degree of Conduction Slowing in Loss-of-Function Sodium Channelopathies. Heart Rhythm., 6, 341-348.
https://doi.org/10.1016/j.hrthm.2008.11.009
|
[31]
|
Sanbe, A. (2013) Dilated Cardiomyopathy: A Disease of the Myocardium. Biol Pharm Bull., 36, 18-22.
https://doi.org/10.1248/bpb.b212023
|
[32]
|
Olson, T.M., Michels, V.V., Ballew, J.D., et al. (2005) Sodium Channel Mutations and Susceptibility to Heart Failure and Atrial Fibrillation. JAMA, 293, 447-454. https://doi.org/10.1001/jama.293.4.447
|
[33]
|
McNair, W.P., Sinagra, G., Taylor, M.R., et al. (2011) SCN5A Mu-tations Associate with Arrhythmic Dilated Cardiomyopathy and Commonly Localize to the Voltage-Sensing Mechanism. J Am Coll Cardiol., 57, 2160-2168.
https://doi.org/10.1016/j.jacc.2010.09.084
|
[34]
|
Moreau, A., Gosselin-Badaroudine, P., Delemotte, L., et al. (2015) Gating Pore Currents Are Defects in Common with Two Nav1.5 Mutations in Patients with Mixed Arrhythmias and Dilated Cardiomyopathy. J Gen Physiol., 145, 93-106.
https://doi.org/10.1085/jgp.201411304
|
[35]
|
Gosselin-Badaroudine, P., Keller, D.I., Huang, H., et al. (2012) A Proton Leak Current through the Cardiac Sodium Channel Is Linked to Mixed Arrhythmia and the Dilated Cardiomyopathy Phenotype. PLoS ONE, 7, e38331.
https://doi.org/10.1371/journal.pone.0038331
|